TreeWAS – Variant ID: rs1633036

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E83.1 Disorders of iron metabolism	1.000	0.000	0.000
L40.9 Psoriasis, unspecified	0.000	0.002	0.998
L40 Psoriasis	0.000	0.006	0.994
L40.5 Arthropathic psoriasis	0.000	0.009	0.991
L40.0 Psoriasis vulgaris	0.000	0.137	0.863
G35 Multiple sclerosis	0.752	0.248	0.000
L40.8 Other psoriasis	0.000	0.251	0.749
L40.4 Guttate psoriasis	0.000	0.287	0.713
L40.3 Pustulosis palmaris et plantaris	0.000	0.287	0.713
L40.2 Acrodermatitis continua	0.000	0.287	0.713
L40.1 Generalised pustular psoriasis	0.000	0.287	0.713
E83 Disorders of mineral metabolism	0.407	0.593	0.000
G35-G37 Demyelinating diseases of the central nervous system	0.302	0.698	0.000
E83.3 Disorders of phosphorus metabolism	0.295	0.705	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.292	0.708	0.000
E83.8 Other disorders of mineral metabolism	0.292	0.708	0.000
E83.2 Disorders of zinc metabolism	0.292	0.708	0.000
E83.0 Disorders of copper metabolism	0.292	0.708	0.000
E89.0 Postprocedural hypothyroidism	0.288	0.712	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.288	0.712	0.000
E70-E90 Metabolic disorders	0.282	0.718	0.000
E89.2 Postprocedural hypoparathyroidism	0.264	0.736	0.000
E83.5 Disorders of calcium metabolism	0.241	0.759	0.000
E84 Cystic fibrosis	0.228	0.772	0.000
E89.4 Postprocedural ovarian failure	0.227	0.773	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.220	0.780	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.218	0.782	0.000
G36 Other acute disseminated demyelination	0.217	0.783	0.000
L40-L45 Papulosquamous disorders	0.020	0.787	0.193
E73 Lactose intolerance	0.211	0.788	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.206	0.793	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.206	0.794	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.206	0.794	0.000
E89.5 Postprocedural testicular hypofunction	0.206	0.794	0.000
E89.1 Postprocedural hypoinsulinaemia	0.206	0.794	0.000
E74 Other disorders of carbohydrate metabolism	0.206	0.794	0.000
E77 Disorders of glycoprotein metabolism	0.202	0.798	0.000
E76 Disorders of glycosaminoglycan metabolism	0.202	0.798	0.000
E72 Other disorders of amino-acid metabolism	0.202	0.798	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.202	0.798	0.000
E70 Disorders of aromatic amino-acid metabolism	0.202	0.798	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.202	0.798	0.000
E88 Other metabolic disorders	0.201	0.799	0.000
E79 Disorders of purine and pyrimidine metabolism	0.198	0.802	0.000
G37 Other demyelinating diseases of central nervous system	0.196	0.804	0.000
E84.9 Cystic fibrosis, unspecified	0.189	0.811	0.000
E80.1 Porphyria cutanea tarda	0.181	0.819	0.000
E80.6 Other disorders of bilirubin metabolism	0.165	0.834	0.000
E84.8 Cystic fibrosis with other manifestations	0.163	0.836	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.163	0.836	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.163	0.836	0.000
E73.9 Lactose intolerance, unspecified	0.161	0.839	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.161	0.839	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.158	0.842	0.000
E80.5 Crigler-Najjar syndrome	0.158	0.842	0.000
E80.3 Defects of catalase and peroxydase	0.158	0.842	0.000
E80.0 Hereditary erythropoietic porphyria	0.158	0.842	0.000
G36.9 Acute disseminated demyelination, unspecified	0.156	0.844	0.000
G36.8 Other specified acute disseminated demyelination	0.156	0.844	0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]	0.156	0.844	0.000
G36.0 Neuromyelitis optica [Devic]	0.156	0.844	0.000
E80.2 Other porphyria	0.156	0.844	0.000
L44 Other papulosquamous disorders	0.015	0.847	0.139
L41 Parapsoriasis	0.015	0.847	0.139
L45 Papulosquamous disorders in diseases classified elsewhere	0.015	0.847	0.139
E75.5 Other lipid storage disorders	0.152	0.847	0.000
E73.8 Other lactose intolerance	0.152	0.848	0.000
E73.1 Secondary lactase deficiency	0.152	0.848	0.000
E73.0 Congenital lactase deficiency	0.152	0.848	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.152	0.848	0.000
E75.6 Lipid storage disorder, unspecified	0.148	0.852	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.148	0.852	0.000
E75.3 Sphingolipidosis, unspecified	0.148	0.852	0.000
E75.2 Other sphingolipidosis	0.148	0.852	0.000
E75.1 Other gangliosidosis	0.148	0.852	0.000
E75.0 GM2 gangliosidosis	0.148	0.852	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.148	0.852	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.148	0.852	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.148	0.852	0.000
E74.2 Disorders of galactose metabolism	0.148	0.852	0.000
E74.1 Disorders of fructose metabolism	0.148	0.852	0.000
E74.0 Glycogen storage disease	0.148	0.852	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.145	0.855	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.145	0.855	0.000
E70.3 Albinism	0.145	0.855	0.000
E70.2 Disorders of tyrosine metabolism	0.145	0.855	0.000
E70.1 Other hyperphenylalaninaemias	0.145	0.855	0.000
E70.0 Classical phenylketonuria	0.145	0.855	0.000
E71.3 Disorders of fatty-acid metabolism	0.145	0.855	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.145	0.855	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.145	0.855	0.000
E71.0 Maple-syrup-urine disease	0.145	0.855	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.145	0.855	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.145	0.855	0.000
E72.5 Disorders of glycine metabolism	0.145	0.855	0.000
E72.4 Disorders of ornithine metabolism	0.145	0.855	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.145	0.855	0.000
E72.2 Disorders of urea cycle metabolism	0.145	0.855	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.145	0.855	0.000
E72.0 Disorders of amino-acid transport	0.145	0.855	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.145	0.855	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.145	0.855	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.145	0.855	0.000
E76.2 Other mucopolysaccharidoses	0.145	0.855	0.000
E76.1 Mucopolysaccharidosis, type II	0.145	0.855	0.000
E76.0 Mucopolysaccharidosis, type I	0.145	0.855	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.145	0.855	0.000
E77.8 Other disorders of glycoprotein metabolism	0.145	0.855	0.000
E77.1 Defects in glycoprotein degradation	0.145	0.855	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.145	0.855	0.000
E88.9 Metabolic disorder, unspecified	0.144	0.856	0.000
E88.8 Other specified metabolic disorders	0.144	0.856	0.000
E88.3 Tumour lysis syndrome	0.144	0.856	0.000
E88.2 Lipomatosis, not elsewhere classified	0.144	0.856	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.142	0.858	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.142	0.858	0.000
E79.1 Lesch-Nyhan syndrome	0.142	0.858	0.000
E80.4 Gilbert's syndrome	0.141	0.859	0.000
E85 Amyloidosis	0.141	0.859	0.000
G37.5 Concentric sclerosis [Balo]	0.140	0.859	0.000
G37.4 Subacute necrotising myelitis	0.140	0.859	0.000
G37.2 Central pontine myelinolysis	0.140	0.859	0.000
G37.1 Central demyelination of corpus callosum	0.140	0.859	0.000
G37.0 Diffuse sclerosis	0.140	0.859	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.138	0.862	0.000
G37.8 Other specified demyelinating diseases of central nervous system	0.137	0.862	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.137	0.863	0.000
L42 Pityriasis rosea	0.016	0.869	0.115
E89.3 Postprocedural hypopituitarism	0.129	0.871	0.000
E83.4 Disorders of magnesium metabolism	0.129	0.871	0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.128	0.872	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.119	0.881	0.000
K70 Alcoholic liver disease	0.112	0.888	0.000
K70.9 Alcoholic liver disease, unspecified	0.112	0.888	0.000
K70.3 Alcoholic cirrhosis of liver	0.111	0.889	0.000
L03.1 Cellulitis of other parts of limb	0.111	0.889	0.000
L41.9 Parapsoriasis, unspecified	0.011	0.890	0.099
L41.8 Other parapsoriasis	0.011	0.890	0.099
L41.5 Retiform parapsoriasis	0.011	0.890	0.099
L41.4 Large plaque parapsoriasis	0.011	0.890	0.099
L41.3 Small plaque parapsoriasis	0.011	0.890	0.099
L41.2 Lymphomatoid papulosis	0.011	0.890	0.099
L41.1 Pityriasis lichenoides chronica	0.011	0.890	0.099
L41.0 Pityriasis lichenoides et varioliformis acuta	0.011	0.890	0.099
L44.9 Papulosquamous disorder, unspecified	0.011	0.890	0.099
L44.8 Other specified papulosquamous disorders	0.011	0.890	0.099
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.011	0.890	0.099
L44.3 Lichen ruber moniliformis	0.011	0.890	0.099
L44.2 Lichen striatus	0.011	0.890	0.099
L44.1 Lichen nitidus	0.011	0.890	0.099
L44.0 Pityriasis rubra pilaris	0.011	0.890	0.099
K70.2 Alcoholic fibrosis and sclerosis of liver	0.102	0.898	0.000
E85.8 Other amyloidosis	0.101	0.899	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.101	0.899	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.101	0.899	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.101	0.899	0.000
L43 Lichen planus	0.018	0.902	0.080
E85.3 Secondary systemic amyloidosis	0.096	0.903	0.000
K70.4 Alcoholic hepatic failure	0.096	0.904	0.000
K70.0 Alcoholic fatty liver	0.093	0.907	0.000
E85.9 Amyloidosis, unspecified	0.083	0.917	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.082	0.918	0.000
E87.5 Hyperkalaemia	0.079	0.921	0.000
E85.4 Organ-limited amyloidosis	0.078	0.921	0.000
I83.9 Varicose veins of lower extremities without ulcer or inflammation	0.079	0.921	0.000
L43.3 Subacute (active) lichen planus	0.013	0.929	0.057
L43.2 Lichenoid drug reaction	0.013	0.929	0.057
L43.1 Bullous lichen planus	0.013	0.929	0.057
L43.0 Hypertrophic lichen planus	0.013	0.929	0.057
L43.8 Other lichen planus	0.013	0.933	0.054
E87.3 Alkalosis	0.061	0.939	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.060	0.940	0.000
E87.4 Mixed disorder of acid-base balance	0.059	0.941	0.000
K70.1 Alcoholic hepatitis	0.058	0.942	0.000
E00-E07 Disorders of thyroid gland	0.057	0.943	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.057	0.943	0.000
E87.7 Fluid overload	0.057	0.943	0.000
E04 Other non-toxic goitre	0.053	0.947	0.000
E06 Thyroiditis	0.053	0.947	0.000
E04.2 Non-toxic multinodular goitre	0.051	0.949	0.000
E06.3 Autoimmune thyroiditis	0.051	0.949	0.000
E87.0 Hyperosmolality and hypernatraemia	0.049	0.951	0.000
E40-E46 Malnutrition	0.047	0.953	0.000
E65-E68 Obesity and other hyperalimentation	0.047	0.953	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.046	0.954	0.000
G25 Other extrapyramidal and movement disorders	0.045	0.955	0.000
E03 Other hypothyroidism	0.043	0.957	0.000
Chapter VI Diseases of the nervous system	0.043	0.957	0.000
E65 Localised adiposity	0.043	0.957	0.000
E04.9 Non-toxic goitre, unspecified	0.043	0.957	0.000
G20-G26 Extrapyramidal and movement disorders	0.042	0.958	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.041	0.959	0.000
E00 Congenital iodine-deficiency syndrome	0.041	0.959	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.041	0.959	0.000
E03.9 Hypothyroidism, unspecified	0.039	0.961	0.000
E04.0 Non-toxic diffuse goitre	0.039	0.961	0.000
E04.8 Other specified non-toxic goitre	0.038	0.961	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.038	0.962	0.000
E46 Unspecified protein-energy malnutrition	0.038	0.962	0.000
E06.5 Other chronic thyroiditis	0.038	0.962	0.000
E06.4 Drug-induced thyroiditis	0.038	0.962	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.038	0.962	0.000
E06.1 Subacute thyroiditis	0.038	0.962	0.000
E06.0 Acute thyroiditis	0.038	0.962	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.038	0.962	0.000
G25.3 Myoclonus	0.037	0.963	0.000
G25.0 Essential tremor	0.037	0.963	0.000
E86 Volume depletion	0.037	0.963	0.000
G30-G32 Other degenerative diseases of the nervous system	0.035	0.965	0.000
G25.9 Extrapyramidal and movement disorder, unspecified	0.035	0.965	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.034	0.966	0.000
E45 Retarded development following protein-energy malnutrition	0.034	0.966	0.000
E43 Unspecified severe protein-energy malnutrition	0.034	0.966	0.000
E42 Marasmic kwashiorkor	0.034	0.966	0.000
E41 Nutritional marasmus	0.034	0.966	0.000
E40 Kwashiorkor	0.034	0.966	0.000
E67 Other hyperalimentation	0.034	0.966	0.000
E68 Sequelae of hyperalimentation	0.034	0.966	0.000
L03 Cellulitis	0.034	0.966	0.000
G83 Other paralytic syndromes	0.033	0.967	0.000
G25.6 Drug-induced tics and other tics of organic origin	0.033	0.967	0.000
G25.5 Other chorea	0.033	0.967	0.000
G25.4 Drug-induced chorea	0.033	0.967	0.000
G25.2 Other specified forms of tremor	0.033	0.967	0.000
G25.1 Drug-induced tremor	0.033	0.967	0.000
E06.9 Thyroiditis, unspecified	0.032	0.967	0.000
G23 Other degenerative diseases of basal ganglia	0.032	0.968	0.000
E04.1 Non-toxic single thyroid nodule	0.032	0.968	0.000
E03.5 Myxoedema coma	0.031	0.969	0.000
E03.4 Atrophy of thyroid (acquired)	0.031	0.969	0.000
E03.3 Postinfectious hypothyroidism	0.031	0.969	0.000
E03.1 Congenital hypothyroidism without goitre	0.031	0.969	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.031	0.969	0.000
G82 Paraplegia and tetraplegia	0.031	0.969	0.000
G21 Secondary Parkinsonism	0.030	0.970	0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.030	0.970	0.000
G22 Parkinsonism in diseases classified elsewhere	0.030	0.970	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.030	0.970	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.030	0.970	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.030	0.970	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.030	0.970	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.030	0.970	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.030	0.970	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.030	0.970	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.030	0.970	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.029	0.970	0.000
E50-E64 Other nutritional deficiencies	0.029	0.970	0.000
E05.9 Thyrotoxicosis, unspecified	0.028	0.972	0.000
G83.4 Cauda equina syndrome	0.028	0.972	0.000
E07 Other disorders of thyroid	0.028	0.972	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.028	0.972	0.000
G82.5 Tetraplegia, unspecified	0.028	0.972	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.028	0.972	0.000
G83.2 Monoplegia of upper limb	0.028	0.972	0.000
I83 Varicose veins of lower extremities	0.028	0.972	0.000
E05.5 Thyroid crisis or storm	0.028	0.972	0.000
E05.4 Thyrotoxicosis factitia	0.028	0.972	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.028	0.972	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.028	0.972	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.028	0.972	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.027	0.972	0.000
G30 Alzheimer's disease	0.027	0.973	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.027	0.973	0.000
L29 Pruritus	0.027	0.973	0.000
L43.9 Lichen planus, unspecified	0.017	0.973	0.010
Y45.0 Opioids and related analgesics	0.027	0.973	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.027	0.973	0.000
G81 Hemiplegia	0.027	0.973	0.000
G83.1 Monoplegia of lower limb	0.027	0.973	0.000
E87.6 Hypokalaemia	0.027	0.973	0.000
Y45.2 Propionic acid derivatives	0.027	0.973	0.000
G90-G99 Other disorders of the nervous system	0.026	0.974	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.026	0.974	0.000
L20-L30 Dermatitis and eczema	0.026	0.974	0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.026	0.974	0.000
G24 Dystonia	0.025	0.974	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	0.024	0.975	0.001
E05.8 Other thyrotoxicosis	0.025	0.975	0.000
E44.1 Mild protein-energy malnutrition	0.025	0.975	0.000
E44.0 Moderate protein-energy malnutrition	0.025	0.975	0.000
L71 Rosacea	0.025	0.975	0.000
L00-L08 Infections of the skin and subcutaneous tissue	0.025	0.975	0.000
E67.8 Other specified hyperalimentation	0.024	0.976	0.000
E67.3 Hypervitaminosis D	0.024	0.976	0.000
E67.2 Megavitamin-B6 syndrome	0.024	0.976	0.000
E67.1 Hypercarotenaemia	0.024	0.976	0.000
E67.0 Hypervitaminosis A	0.024	0.976	0.000
L29.0 Pruritus ani	0.024	0.976	0.000
G23.8 Other specified degenerative diseases of basal ganglia	0.024	0.976	0.000
G83.5 Locked-in syndrome	0.024	0.976	0.000
G83.3 Monoplegia, unspecified	0.024	0.976	0.000
G83.0 Diplegia of upper limbs	0.024	0.976	0.000
L29.8 Other pruritus	0.024	0.976	0.000
G83.9 Paralytic syndrome, unspecified	0.024	0.976	0.000
L60-L75 Disorders of skin appendages	0.024	0.976	0.000
L03.8 Cellulitis of other sites	0.024	0.976	0.000
L29.9 Pruritus, unspecified	0.023	0.977	0.000
G31.2 Degeneration of nervous system due to alcohol	0.023	0.977	0.000
G82.1 Spastic paraplegia	0.023	0.977	0.000
G23.9 Degenerative disease of basal ganglia, unspecified	0.023	0.977	0.000
G23.3 Multiple system atrophy, cerebellar type	0.023	0.977	0.000
G23.2 Striatonigral degeneration	0.023	0.977	0.000
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]	0.023	0.977	0.000
G23.0 Hallervorden-Spatz disease	0.023	0.977	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.023	0.977	0.000
G80 Infantile cerebral palsy	0.023	0.977	0.000
G30.0 Alzheimer's disease with early onset	0.023	0.977	0.000
L21 Seborrhoeic dermatitis	0.023	0.977	0.000
L71.1 Rhinophyma	0.023	0.977	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.023	0.977	0.000
G82.3 Flaccid tetraplegia	0.022	0.978	0.000
G82.0 Flaccid paraplegia	0.022	0.978	0.000
L04 Acute lymphadenitis	0.022	0.978	0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.022	0.978	0.000
E03.8 Other specified hypothyroidism	0.022	0.978	0.000
G95 Other diseases of spinal cord	0.022	0.978	0.000
G21.9 Secondary Parkinsonism, unspecified	0.022	0.978	0.000
G21.8 Other secondary Parkinsonism	0.022	0.978	0.000
G21.4 Vascular parkinsonism	0.022	0.978	0.000
G21.3 Postencephalitic Parkinsonism	0.022	0.978	0.000
G21.2 Secondary Parkinsonism due to other external agents	0.022	0.978	0.000
G21.1 Other drug-induced secondary Parkinsonism	0.022	0.978	0.000
G21.0 Malignant neuroleptic syndrome	0.022	0.978	0.000
L71.9 Rosacea, unspecified	0.022	0.978	0.000
E58 Dietary calcium deficiency	0.022	0.978	0.000
Y45.8 Other analgesics and antipyretics	0.022	0.978	0.000
G81.1 Spastic hemiplegia	0.022	0.978	0.000
Y45.5 4-Aminophenol derivatives	0.022	0.978	0.000
K70-K77 Diseases of liver	0.022	0.978	0.000
G06 Intracranial and intraspinal abscess and granuloma	0.022	0.978	0.000
L29.2 Pruritus vulvae	0.022	0.978	0.000
E51 Thiamine deficiency	0.022	0.978	0.000
L20 Atopic dermatitis	0.022	0.978	0.000
E15 Nondiabetic hypoglycaemic coma	0.021	0.978	0.000
E20-E35 Disorders of other endocrine glands	0.021	0.978	0.000
Y44 Agents primarily affecting blood constituents	0.021	0.979	0.000
G30.8 Other Alzheimer's disease	0.021	0.979	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.021	0.979	0.000
E63 Other nutritional deficiencies	0.021	0.979	0.000
E56 Other vitamin deficiencies	0.021	0.979	0.000
E50 Vitamin A deficiency	0.021	0.979	0.000
E60 Dietary zinc deficiency	0.021	0.979	0.000
E59 Dietary selenium deficiency	0.021	0.979	0.000
E54 Ascorbic acid deficiency	0.021	0.979	0.000
E52 Niacin deficiency [pellagra]	0.021	0.979	0.000
G93 Other disorders of brain	0.021	0.979	0.000
G10 Huntington's disease	0.021	0.979	0.000
G82.2 Paraplegia, unspecified	0.021	0.979	0.000
L71.8 Other rosacea	0.021	0.979	0.000
G93.4 Encephalopathy, unspecified	0.021	0.979	0.000
I83.0 Varicose veins of lower extremities with ulcer	0.021	0.979	0.000
G96 Other disorders of central nervous system	0.021	0.979	0.000
G03 Meningitis due to other and unspecified causes	0.021	0.979	0.000
L21.9 Seborrhoeic dermatitis, unspecified	0.021	0.979	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.021	0.979	0.000
E53 Deficiency of other B group vitamins	0.021	0.979	0.000
L73 Other follicular disorders	0.021	0.979	0.000
L03.9 Cellulitis, unspecified	0.020	0.979	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.020	0.980	0.000
E07.1 Dyshormogenetic goitre	0.020	0.980	0.000
E07.0 Hypersecretion of calcitonin	0.020	0.980	0.000
G83.8 Other specified paralytic syndromes	0.020	0.980	0.000
G31.0 Circumscribed brain atrophy	0.020	0.980	0.000
L03.2 Cellulitis of face	0.020	0.980	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.020	0.980	0.000
Y44.2 Anticoagulants	0.020	0.980	0.000
G98 Other disorders of nervous system, not elsewhere classified	0.020	0.980	0.000
G24.8 Other dystonia	0.020	0.980	0.000
I83.2 Varicose veins of lower extremities with both ulcer and inflammation	0.020	0.980	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.020	0.980	0.000
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere	0.020	0.980	0.000
G14 Postpolio syndrome	0.020	0.980	0.000
G30.1 Alzheimer's disease with late onset	0.020	0.980	0.000
G11 Hereditary ataxia	0.020	0.980	0.000
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.020	0.980	0.000
Y48 Anaesthetics and therapeutic gases	0.020	0.980	0.000
L04.9 Acute lymphadenitis, unspecified	0.020	0.980	0.000
L29.3 Anogenital pruritus, unspecified	0.020	0.980	0.000
L29.1 Pruritus scroti	0.020	0.980	0.000
K76 Other diseases of liver	0.020	0.980	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.020	0.980	0.000
Y45.4 Antirheumatics	0.020	0.980	0.000
G95.8 Other specified diseases of spinal cord	0.020	0.980	0.000
G81.0 Flaccid hemiplegia	0.019	0.980	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.019	0.981	0.000
G82.4 Spastic tetraplegia	0.019	0.981	0.000
G95.0 Syringomyelia and syringobulbia	0.019	0.981	0.000
L63 Alopecia areata	0.019	0.981	0.000
Q25 Congenital malformations of great arteries	0.019	0.981	0.000
G92 Toxic encephalopathy	0.019	0.981	0.000
G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere	0.019	0.981	0.000
G00 Bacterial meningitis, not elsewhere classified	0.019	0.981	0.000
L03.3 Cellulitis of trunk	0.019	0.981	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.019	0.981	0.000
E34 Other endocrine disorders	0.019	0.981	0.000
L04.1 Acute lymphadenitis of trunk	0.019	0.981	0.000
Y54.5 Other diuretics	0.019	0.981	0.000
L24 Irritant contact dermatitis	0.019	0.981	0.000
L26 Exfoliative dermatitis	0.019	0.981	0.000
L22 Diaper [napkin] dermatitis	0.019	0.981	0.000
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.019	0.981	0.000
G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere	0.019	0.981	0.000
G93.8 Other specified disorders of brain	0.019	0.981	0.000
G93.1 Anoxic brain damage, not elsewhere classified	0.019	0.981	0.000
Q24 Other congenital malformations of heart	0.019	0.981	0.000
G24.3 Spasmodic torticollis	0.019	0.981	0.000
L20.9 Atopic dermatitis, unspecified	0.019	0.981	0.000
L73.8 Other specified follicular disorders	0.019	0.981	0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.018	0.981	0.000
G24.4 Idiopathic orofacial dystonia	0.018	0.981	0.000
G24.2 Idiopathic nonfamilial dystonia	0.018	0.981	0.000
G24.1 Idiopathic familial dystonia	0.018	0.981	0.000
G24.0 Drug-induced dystonia	0.018	0.981	0.000
G06.1 Intraspinal abscess and granuloma	0.018	0.981	0.000
Q23 Congenital malformations of aortic and mitral valves	0.018	0.982	0.000
L68 Hypertrichosis	0.018	0.982	0.000
K76.6 Portal hypertension	0.018	0.982	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.018	0.982	0.000
L30 Other dermatitis	0.018	0.982	0.000
G94 Other disorders of brain in diseases classified elsewhere	0.018	0.982	0.000
L01 Impetigo	0.018	0.982	0.000
L28 Lichen simplex chronicus and prurigo	0.018	0.982	0.000
E07.8 Other specified disorders of thyroid	0.018	0.982	0.000
L71.0 Perioral dermatitis	0.018	0.982	0.000
L00 Staphylococcal scalded skin syndrome	0.018	0.982	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.018	0.982	0.000
Q24.8 Other specified congenital malformations of heart	0.018	0.982	0.000
E27 Other disorders of adrenal gland	0.018	0.982	0.000
Q23.1 Congenital insufficiency of aortic valve	0.018	0.982	0.000
L23 Allergic contact dermatitis	0.017	0.982	0.000
L66 Cicatricial alopecia [scarring hair loss]	0.017	0.982	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.017	0.983	0.000
Q25.1 Coarctation of aorta	0.017	0.983	0.000
L75 Apocrine sweat disorders	0.017	0.983	0.000
L74 Eccrine sweat disorders	0.017	0.983	0.000
L67 Hair colour and hair shaft abnormalities	0.017	0.983	0.000
L64 Androgenic alopecia	0.017	0.983	0.000
L62 Nail disorders in diseases classified elsewhere	0.017	0.983	0.000
E87.2 Acidosis	0.017	0.983	0.000
L10-L14 Bullous disorders	0.016	0.983	0.001
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.017	0.983	0.000
L73.2 Hidradenitis suppurativa	0.017	0.983	0.000
L65 Other nonscarring hair loss	0.017	0.983	0.000
G24.9 Dystonia, unspecified	0.017	0.983	0.000
L70 Acne	0.017	0.983	0.000
Y48.3 Local anaesthetics	0.017	0.983	0.000
G80.2 Infantile hemiplegia	0.017	0.983	0.000
G09 Sequelae of inflammatory diseases of central nervous system	0.017	0.983	0.000
G70-G73 Diseases of myoneural junction and muscle	0.017	0.983	0.000
E25 Adrenogenital disorders	0.017	0.983	0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.017	0.983	0.000
L25 Unspecified contact dermatitis	0.017	0.983	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.017	0.983	0.000
K75 Other inflammatory liver diseases	0.017	0.983	0.000
G80.8 Other infantile cerebral palsy	0.016	0.983	0.000
G80.4 Ataxic cerebral palsy	0.016	0.983	0.000
G80.3 Dyskinetic cerebral palsy	0.016	0.983	0.000
G80.1 Spastic diplegia	0.016	0.983	0.000
G80.0 Spastic cerebral palsy	0.016	0.983	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.017	0.983	0.000
L21.8 Other seborrhoeic dermatitis	0.016	0.983	0.000
L21.1 Seborrhoeic infantile dermatitis	0.016	0.983	0.000
L21.0 Seborrhoea capitis	0.016	0.983	0.000
Q89.2 Congenital malformations of other endocrine glands	0.017	0.983	0.000
Y54.7 Agents affecting calcification	0.017	0.983	0.000
Y54.4 Loop [high-ceiling] diuretics	0.016	0.983	0.000
G95.2 Cord compression, unspecified	0.017	0.983	0.000
G93.3 Postviral fatigue syndrome	0.017	0.983	0.000
K90.0 Coeliac disease	0.000	0.983	0.017
E20 Hypoparathyroidism	0.016	0.983	0.000
K76.8 Other specified diseases of liver	0.017	0.983	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.016	0.983	0.000
Y58 Bacterial vaccines	0.016	0.984	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.016	0.984	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.016	0.984	0.000
L27 Dermatitis due to substances taken internally	0.016	0.984	0.000
G11.4 Hereditary spastic paraplegia	0.016	0.984	0.000
G06.2 Extradural and subdural abscess, unspecified	0.016	0.984	0.000
Chapter XX External causes of morbidity and mortality	0.016	0.984	0.000
Y48.4 Anaesthetic, unspecified	0.016	0.984	0.000
G96.1 Disorders of meninges, not elsewhere classified	0.016	0.984	0.000
L04.8 Acute lymphadenitis of other sites	0.016	0.984	0.000
L04.3 Acute lymphadenitis of lower limb	0.016	0.984	0.000
L04.2 Acute lymphadenitis of upper limb	0.016	0.984	0.000
G20 Parkinson's disease	0.016	0.984	0.000
G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere	0.016	0.984	0.000
G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere	0.016	0.984	0.000
G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere	0.016	0.984	0.000
Y59 Other and unspecified vaccines and biological substances	0.016	0.984	0.000
L04.0 Acute lymphadenitis of face, head and neck	0.016	0.984	0.000
G99 Other disorders of nervous system in diseases classified elsewhere	0.016	0.984	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.016	0.984	0.000
E10.9 Without complications	0.000	0.984	0.016
Y49 Psychotropic drugs, not elsewhere classified	0.016	0.984	0.000
E51.2 Wernicke's encephalopathy	0.016	0.984	0.000
Q89 Other congenital malformations, not elsewhere classified	0.016	0.984	0.000
L63.9 Alopecia areata, unspecified	0.016	0.984	0.000
G30.9 Alzheimer's disease, unspecified	0.016	0.984	0.000
K77 Liver disorders in diseases classified elsewhere	0.016	0.984	0.000
K71 Toxic liver disease	0.016	0.984	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations